These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds. Harats M; Haik J; Cleary M; Vashurin I; Aviv U; Kornhaber R Isr Med Assoc J; 2020 Feb; 22(2):83-88. PubMed ID: 32043324 [TBL] [Abstract][Full Text] [Related]
5. Enzymatic debridement of hands with deep burns: a single center experience in the treatment of 52 hands. Dadras M; Wagner JM; Wallner C; Sogorski A; Sacher M; Harati K; Lehnhardt M; Behr B J Plast Surg Hand Surg; 2020 Aug; 54(4):220-224. PubMed ID: 32315252 [No Abstract] [Full Text] [Related]
6. Assessing the Effect of Enzymatic Debridement on the Scar Quality in Partial-Thickness Burns to Deep Dermal Burns of the Hand: A Long-Term Evaluation. Heitzmann W; Schulz A; Fuchs PC; Schiefer JL Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541207 [No Abstract] [Full Text] [Related]
7. Limitations to the use of bromelain-based enzymatic debridement (NexoBrid Berner JE; Keckes D; Pywell M; Dheansa B Scars Burn Heal; 2018; 4():2059513118816534. PubMed ID: 30574406 [TBL] [Abstract][Full Text] [Related]
8. Enzymatic debridement: past, present, and future. De Decker I; De Graeve L; Hoeksema H; Monstrey S; Verbelen J; De Coninck P; Vanlerberghe E; Claes KEY Acta Chir Belg; 2022 Aug; 122(4):279-295. PubMed ID: 35440290 [TBL] [Abstract][Full Text] [Related]
9. An Overview of the Use of Bromelain-Based Enzymatic Debridement (Nexobrid®) in Deep Partial and Full Thickness Burns: Appraising the Evidence. Loo YL; Goh BKL; Jeffery S J Burn Care Res; 2018 Oct; 39(6):932-938. PubMed ID: 29579268 [TBL] [Abstract][Full Text] [Related]
10. Enzymatic debridement for circumferential deep burns: the role of surgical escharotomy. Grünherz L; Michienzi R; Schaller C; Rittirsch D; Uyulmaz S; Kim BS; Giovanoli P; Lindenblatt N Burns; 2023 Mar; 49(2):304-309. PubMed ID: 36604280 [TBL] [Abstract][Full Text] [Related]
11. Preliminary Single-Center Experience of Bromelain-Based Eschar Removal in Children with Mixed Deep Dermal and Full Thickness Burns. Korzeniowski T; Grywalska E; Strużyna J; Bugaj-Tobiasz M; Surowiecka A; Korona-Głowniak I; Staśkiewicz M; Torres K J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013039 [TBL] [Abstract][Full Text] [Related]
12. Bromelain-based enzymatic debridement and minimal invasive modality (mim) care of deeply burned hands. Krieger Y; Rubin G; Schulz A; Rosenberg N; Levi A; Singer AJ; Rosenberg L; Shoham Y Ann Burns Fire Disasters; 2017 Sep; 30(3):198-204. PubMed ID: 29849523 [TBL] [Abstract][Full Text] [Related]
13. Our initial learning curve in the enzymatic debridement of severely burned hands-Management and pit falls of initial treatments and our development of a post debridement wound treatment algorithm. Schulz A; Perbix W; Shoham Y; Daali S; Charalampaki C; Fuchs PC; Schiefer J Burns; 2017 Mar; 43(2):326-336. PubMed ID: 28341257 [TBL] [Abstract][Full Text] [Related]
14. Enzymatic Debridement of Deep Thermal Burns in the Russian Federation: First Experience. Alekseev AA; Malyutina NB; Bobrovnikov AE; Shoham Y Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836845 [TBL] [Abstract][Full Text] [Related]
15. Enzymatic debridement of deeply burned faces: Healing and early scarring based on tissue preservation compared to traditional surgical debridement. Schulz A; Fuchs PC; Rothermundt I; Hoffmann A; Rosenberg L; Shoham Y; Oberländer H; Schiefer J Burns; 2017 Sep; 43(6):1233-1243. PubMed ID: 28363663 [TBL] [Abstract][Full Text] [Related]
16. Bromelain-based enzymatic debridement as a treatment of choice in high-risk patient with deep facial burns, a case report. Ferancikova N; Bukovcan P; Sarkozyova N; Dragunova J; Cucorova V; Koller J Int J Surg Case Rep; 2020; 71():6-10. PubMed ID: 32428831 [TBL] [Abstract][Full Text] [Related]
17. Historical Perspectives on the Development of Current Standards of Care for Enzymatic Debridement. Heitzmann W; Fuchs PC; Schiefer JL Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33348927 [No Abstract] [Full Text] [Related]
18. A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines. Korzeniowski T; Strużyna J; Chrapusta AM; Krajewski A; Kucharzewski M; Piorun K; Nowakowski J; Surowiecka A; Kozicka M; Torres K Med Sci Monit; 2022 Jan; 28():e935632. PubMed ID: 35064095 [TBL] [Abstract][Full Text] [Related]
19. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update. Hirche C; Kreken Almeland S; Dheansa B; Fuchs P; Governa M; Hoeksema H; Korzeniowski T; Lumenta DB; Marinescu S; Martinez-Mendez JR; Plock JA; Sander F; Ziegler B; Kneser U Burns; 2020 Jun; 46(4):782-796. PubMed ID: 32241591 [TBL] [Abstract][Full Text] [Related]